MARKET

CRMD

CRMD

Cormedix
NASDAQ
11.90
-0.29
-2.38%
Opening 12:15 01/06 EST
OPEN
12.24
PREV CLOSE
12.19
HIGH
12.29
LOW
11.87
VOLUME
1.38M
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
937.59M
P/E (TTM)
5.80
1D
5D
1M
3M
1Y
5Y
1D
INCY's Phase III Monjuvi Study Meets Key Goals in First-Line Lymphoma
NASDAQ · 7h ago
Intellia Stock Declines Around 55% in 3 Months: Here's Why
NASDAQ · 1d ago
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026
NASDAQ · 1d ago
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
NASDAQ · 1d ago
Weekly Report: what happened at CRMD last week (1229-0102)?
Weekly Report · 1d ago
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
NASDAQ · 4d ago
AXSM Up on FDA Priority Review to AXS-05 sNDA in Alzheimer's Agitation
NASDAQ · 4d ago
Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism
NASDAQ · 4d ago
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.